Read More Pharma Industry News Dr. Reddy’s Labs to sell certain rights for ELYXYB to BioDelivery Sciences Dr. Reddy’s Laboratories (Dr. Reddy’s Labs) has agreed to divest its US and Canada rights for migraine drug… bySrinathAugust 5, 2021
